VVOS Stock Performance, Insider Transaction and News

VVOS - Vivos Therapeutics, Inc.

Market Cap	8.86M	P/E	-	EPS this Y	69.50%	Ern Qtrly Grth	-
Income	-13.58M	Forward P/E	-2.96	EPS next Y	32.90%	50D Avg Chg	-29.00%
Sales	13.8M	PEG	-	EPS past 5Y	-	200D Avg Chg	-50.00%
Dividend	N/A	Price/Book	1.26	EPS next 5Y	-	52W High Chg	-90.00%
Recommedations	2.00	Quick Ratio	0.25	Shares Outstanding	2.98M	52W Low Chg	29.00%
Insider Own	7.39%	ROA	-88.43%	Shares Float	1.93M	Beta	7.90
Inst Own	13.73%	ROE	-521.22%	Shares Shorted/Prior	18.69K/23.57K	Price	0.30
Gross Margin	59.93%	Profit Margin	-98.42%	Avg. Volume	247,695	Target Price	7.22
Oper. Margin	-127.25%	Earnings Date	Jun 6	Volume	195,279	Change	2.14%

Healthcare | Medical Devices | United States

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.

Vivos Therapeutics, Inc. News

04/09/24	Vivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devices
04/09/24	Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
04/01/24	Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2023 Earnings Call Transcript
03/31/24	Vivos Therapeutics Full Year 2023 Earnings: Misses Expectations
03/28/24	Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
03/28/24	Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
02/22/24	3 Stocks to Turn $1,000 Into $1 Million: February 2024
02/15/24	Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds
02/12/24	Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions
02/06/24	Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
01/08/24	Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA
12/11/23	Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”
11/30/23	Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea
11/29/23	Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea
11/29/23	UPDATE 2-US FDA clears Vivos Therapeutics' oral device for sleep apnea
11/29/23	Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
11/14/23	Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update
11/09/23	Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call
11/03/23	Vivos Therapeutics agrees to nationwide distribution deal with in-home respiratory dealer Lincare
11/02/23	Vivos Therapeutics Closes $4 Million Private Placement

VVOS Chatroom

JG1111 Posted - 1 hour ago

$VVOS exactly!

ReversalSwingTrading Posted - 10 hours ago

$COOT $VVOS these can fly next!!!🙌🏽👍🚀🚀🚀🚀🚀

Giovannirs3 Posted - 10 hours ago

$VVOS 🐖

DankeDude Posted - 11 hours ago

$VVOS competitor $osa just got delisted. VVOS is next because they're lazy and incompetent. They didn't even release an 8k for the recent patent they got within 4 days per SEC disclosure requirements and that's just another violation.

Giovannirs3 Posted - 14 hours ago

$VVOS 👍

cluvin Posted - 14 hours ago

$VVOS now it is easy to make your money buy $TWG low volume this is going above 50% today get in early

NickyProfits Posted - 1 day ago

@Mmurphy50 @Mrs_BlackINKEconomics $VVOS has been a huge failure. Wait for confirmation. Don’t be bag holder like myself. I’m down 50% News has been pending for ever

Giovannirs3 Posted - 1 day ago

$VVOS Biggest Nasdaq Scam. nothing else.

Unique18Bad Posted - 1 day ago

$VVOS wouldn’t wanna be short on this once this launch 🚀

TomMac64 Posted - 1 day ago

$VVOS The Eli news is not good ?

ReversalSwingTrading Posted - 2 days ago

$VVOS ready for the next pump here!!!👀🔥

jeffthechef Posted - 2 days ago

$VVOS Can be a deadly ☠ condition. Had by millions. Up to 5-10% of people world wide have the condition! On Nov. 29, 2023, Vivos Therapeutics announced it received FDA 510(k) clearance for its line of Complete Airway Repositioning and/or Expansion (CARE) oral appliances for the treatment of severe obstructive sleep apnea (OSA). Medicare approved for payment, effective immedietly ! November- Signs nationwide distribution deal. Do your DD. WAY OVERSOLD!

vikingtrader44 Posted - 3 days ago

$VVOS posting this here for anyone curious on how this actually operates

DLT4489 Posted - 3 days ago

$MOB see? I told you an hour ago 🤣🤣🤣 $grrr $OBLG $VVOS .....

Moneyybaggs Posted - 3 days ago

$VVOS These guys get bought by a much bigger company with far greater market reach and penetration. Medicare approval was a BIG DEAL and will be a big deal going forward.

Ramon1979 Posted - 3 days ago

$VVOS travelers to the train!! we're going up

RollingDollar Posted - 3 days ago

$VVOS

Mmurphy50 Posted - 3 days ago

@Mrs_BlackINKEconomics did Kyle have any thoughts on $VVOS ?

vikingtrader44 Posted - 4 days ago

$VVOS This is an amazing product that has significantly improved my sleep quality and breathing ability. I just wish it wasn’t such a process for them to acquire new users

FyCkD_FuNnY Posted - 5 days ago

$VVOS 14 Posts after this one... Down 78%, for the sake of transparency, show a current screenshot of your position... You get paid when you Post or Trade🙊🙉🙈

DLT4489 Posted - 6 days ago

$CSPI just wanted to remind you again, @ACInvestorBlog is a filthy monster, be careful $vvos, $GRRR ,$OBLG ,..... 90% of his stocks are down biiig time.

TomMac64 Posted - 6 days ago

$VVOS sorry wrong board .

TomMac64 Posted - 6 days ago

$VVOS Take a good look at Monday open these pricks knew right then where they would drive the price on the road to Friday that’s the scam of the NYSE !

jeffthechef Posted - 6 days ago

@ACInvestorBlog $VVOS added more!

Mmurphy50 Posted - 6 days ago

$VVOS @Mrs_BlackINKEconomics

TomMac64 Posted - 6 days ago

$VVOS yes ! this recall of CRAP coupled with VIVOS good fundamentals make this attractive .

Mmurphy50 Posted - 6 days ago

$VVOS @Mrs_BlackINKEconomics

ChaosSmiles88 Posted - 6 days ago

$VVOS FDA &Medicare reimbursement approval are just the beginning. However the recalls of continuous positive airway pressure (CPAP) devices have left millions of OSA sufferers searching for alternative treatments are creating a significant opportunity for Vivos. This stock is so undervalued.

Mmurphy50 Posted - 6 days ago

$VVOS @YoloAlfred

Ramon1979 Posted - 6 days ago

$VVOS go to 5$ the análisis mine.

Insider Trades	Relationship	Date	Transactions	Cost($)	#Shares	Value($)	#Share Own	SEC Form 4
Huntsman Ronald Kirk	Chief Executive Offi.. Chief Executive Officer	Jun 20	Buy	0.53	14,000	7,420	86,521	06/20/23
Huntsman Ronald Kirk	Chief Executive Offi.. Chief Executive Officer	Jun 15	Buy	0.52	15,021	7,811	72,521	06/20/23
Huntsman Ronald Kirk	Chief Executive Offi.. Chief Executive Officer	Jun 14	Buy	0.49	10,000	4,900	57,500	06/15/23
Huntsman Ronald Kirk	Chief Executive Offi.. Chief Executive Officer	Dec 23	Buy	0.50	20,000	10,000	47,500	12/28/22
Huntsman Ronald Kirk	Chief Executive Offi.. Chief Executive Officer	May 31	Buy	1.93	12,000	23,160	27,500	06/03/22